<DOC>
	<DOCNO>NCT01501890</DOCNO>
	<brief_summary>The purpose study investigate whether treatment progesterone patient first trim vaginal bleeding alter rate obstetrical complication adverse pregnancy outcome .</brief_summary>
	<brief_title>Progesterone First Trimester Vaginal Bleeding</brief_title>
	<detailed_description>First trim vaginal bleed one common pregnancy complication affect 15-25 % pregnancy . Threatened abortion define bleed closed cervical o first half pregnancy . A subchorionic hematoma ( SCH ) find 18-39 % woman threaten miscarriage around 70 % woman SCH experience vaginal bleeding . Data relationship first trim vaginal bleeding obstetric outcome describe mainly retrospective noncontrolled study . It hypothesize first trim bleed indicator general tendency complication ( : preterm premature rupture membrane ( PPROM ) , preterm delivery ( &lt; 37 week gestation ; PTD ) low birth weight ( &lt; 1500g ; LBW ) neonates , small gestational age ( SGA ) neonates , placenta previa , placental abruption stillbirth ) later pregnancy . Nowadays , scientific base treatment prevention complication associate SCH vaginal bleeding . Nevertheless , recent data suggest prophylactic administration progesterone lead significant reduction rate preterm delivery SGA neonate among patient PTD SGA neonates past . Although progesterone administration threaten miscarriage study , many physician treat patient first trim vaginal bleeding progesterone . In era evidence base medicine , researcher aim investigate whether treatment progesterone patient first trim vaginal bleeding alter rate obstetrical complication adverse pregnancy outcome . The researcher hypothesize treatment progesterone first trim vaginal bleeding alter rate mention obstetrical complication adverse pregnancy outcome .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Abortion , Threatened</mesh_term>
	<mesh_term>Abruptio Placentae</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Algestone</mesh_term>
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>Low risk pregnancy Intrauterine pregnancy document sonographically Singleton pregnancy Known gestational age Healthy woman Women reproductive assistant technique Women treat progesterone Multiple pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Threatened Abortion</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Subchorionic Hematoma</keyword>
	<keyword>Pre-Eclampsia</keyword>
	<keyword>Abruptio Placentae</keyword>
	<keyword>Fetal Growth Retardation</keyword>
	<keyword>Premature Birth</keyword>
</DOC>